Editor
Pinar O. Eser
  • Post-Doc, Dana-Farber Cancer Institute
Research focus
  • Cancer biology
  • Lung cancer, targeted therapy, acquired drug resistance
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.